0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Post herpetic Neuralgia Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-29M2276
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Post herpetic Neuralgia Treatment Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Post herpetic Neuralgia Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-29M2276
Report
April 2024
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Post herpetic Neuralgia Treatment - Market Size

The global market for Post herpetic Neuralgia Treatment was estimated to be worth US$ 1586 million in 2023 and is forecast to a readjusted size of US$ 2093.9 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030

Post herpetic Neuralgia Treatment - Market

Post herpetic Neuralgia Treatment - Market

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Post herpetic Neuralgia Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Post herpetic Neuralgia Treatment by region & country, by Type, and by Distribution Channel.
The Post herpetic Neuralgia Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post herpetic Neuralgia Treatment.
Market Segmentation

Scope of Post herpetic Neuralgia Treatment - Market Report

Report Metric Details
Report Name Post herpetic Neuralgia Treatment - Market
Forecasted market size in 2030 US$ 2093.9 million
CAGR 4.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Anticonvulsants
  • Skin Patch
  • Other
Segment by Distribution Channel
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, Teva, Mylan, Hengrui Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Post herpetic Neuralgia Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Post herpetic Neuralgia Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Post herpetic Neuralgia Treatment in country level. It provides sigmate data by Type, and by Distribution Channel for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Post herpetic Neuralgia Treatment - Market size in 2030?

Ans: The Post herpetic Neuralgia Treatment - Market size in 2030 will be US$ 2093.9 million.

What is the market share of major companies in Post herpetic Neuralgia Treatment - Market?

Ans: Global top five manufacturers hold a share about 80%.

What is the Post herpetic Neuralgia Treatment - Market share by type?

Ans: In terms of product, Anticonvulsants is the largest segment, with a share over 80%.

Who are the main players in the Post herpetic Neuralgia Treatment - Market report?

Ans: The main players in the Post herpetic Neuralgia Treatment - Market are Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, Teva, Mylan, Hengrui Medicine

What are the Type segmentation covered in the Post herpetic Neuralgia Treatment - Market report?

Ans: The Types covered in the Post herpetic Neuralgia Treatment - Market report are Anticonvulsants, Skin Patch, Other

1 Market Overview
1.1 Post herpetic Neuralgia Treatment Product Introduction
1.2 Global Post herpetic Neuralgia Treatment Market Size Forecast
1.3 Post herpetic Neuralgia Treatment Market Trends & Drivers
1.3.1 Post herpetic Neuralgia Treatment Industry Trends
1.3.2 Post herpetic Neuralgia Treatment Market Drivers & Opportunity
1.3.3 Post herpetic Neuralgia Treatment Market Challenges
1.3.4 Post herpetic Neuralgia Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Post herpetic Neuralgia Treatment Players Revenue Ranking (2023)
2.2 Global Post herpetic Neuralgia Treatment Revenue by Company (2019-2024)
2.3 Key Companies Post herpetic Neuralgia Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Post herpetic Neuralgia Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Post herpetic Neuralgia Treatment
2.6 Post herpetic Neuralgia Treatment Market Competitive Analysis
2.6.1 Post herpetic Neuralgia Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Post herpetic Neuralgia Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post herpetic Neuralgia Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Anticonvulsants
3.1.2 Skin Patch
3.1.3 Other
3.2 Global Post herpetic Neuralgia Treatment Sales Value by Type
3.2.1 Global Post herpetic Neuralgia Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Post herpetic Neuralgia Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Post herpetic Neuralgia Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Distribution Channel
4.1 Introduction by Distribution Channel
4.1.1 Hospital Pharmacies
4.1.2 Online Pharmacies
4.1.3 Retail Pharmacies
4.2 Global Post herpetic Neuralgia Treatment Sales Value by Distribution Channel
4.2.1 Global Post herpetic Neuralgia Treatment Sales Value by Distribution Channel (2019 VS 2023 VS 2030)
4.2.2 Global Post herpetic Neuralgia Treatment Sales Value, by Distribution Channel (2019-2030)
4.2.3 Global Post herpetic Neuralgia Treatment Sales Value, by Distribution Channel (%) (2019-2030)
5 Segmentation by Region
5.1 Global Post herpetic Neuralgia Treatment Sales Value by Region
5.1.1 Global Post herpetic Neuralgia Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Post herpetic Neuralgia Treatment Sales Value by Region (2019-2024)
5.1.3 Global Post herpetic Neuralgia Treatment Sales Value by Region (2025-2030)
5.1.4 Global Post herpetic Neuralgia Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Post herpetic Neuralgia Treatment Sales Value, 2019-2030
5.2.2 North America Post herpetic Neuralgia Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Post herpetic Neuralgia Treatment Sales Value, 2019-2030
5.3.2 Europe Post herpetic Neuralgia Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Post herpetic Neuralgia Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Post herpetic Neuralgia Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Post herpetic Neuralgia Treatment Sales Value, 2019-2030
5.5.2 South America Post herpetic Neuralgia Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Post herpetic Neuralgia Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Post herpetic Neuralgia Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Post herpetic Neuralgia Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Post herpetic Neuralgia Treatment Sales Value
6.3 United States
6.3.1 United States Post herpetic Neuralgia Treatment Sales Value, 2019-2030
6.3.2 United States Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Post herpetic Neuralgia Treatment Sales Value by Distribution Channel, 2023 VS 2030
6.4 Europe
6.4.1 Europe Post herpetic Neuralgia Treatment Sales Value, 2019-2030
6.4.2 Europe Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Post herpetic Neuralgia Treatment Sales Value by Distribution Channel, 2023 VS 2030
6.5 China
6.5.1 China Post herpetic Neuralgia Treatment Sales Value, 2019-2030
6.5.2 China Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Post herpetic Neuralgia Treatment Sales Value by Distribution Channel, 2023 VS 2030
6.6 Japan
6.6.1 Japan Post herpetic Neuralgia Treatment Sales Value, 2019-2030
6.6.2 Japan Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Post herpetic Neuralgia Treatment Sales Value by Distribution Channel, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Post herpetic Neuralgia Treatment Sales Value, 2019-2030
6.7.2 South Korea Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Post herpetic Neuralgia Treatment Sales Value by Distribution Channel, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Post herpetic Neuralgia Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Post herpetic Neuralgia Treatment Sales Value by Distribution Channel, 2023 VS 2030
6.9 India
6.9.1 India Post herpetic Neuralgia Treatment Sales Value, 2019-2030
6.9.2 India Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Post herpetic Neuralgia Treatment Sales Value by Distribution Channel, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer Post herpetic Neuralgia Treatment Products, Services and Solutions
7.1.4 Pfizer Post herpetic Neuralgia Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 Arbor Pharma
7.2.1 Arbor Pharma Profile
7.2.2 Arbor Pharma Main Business
7.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Products, Services and Solutions
7.2.4 Arbor Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Arbor Pharma Recent Developments
7.3 Assertio Therapeutics
7.3.1 Assertio Therapeutics Profile
7.3.2 Assertio Therapeutics Main Business
7.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Products, Services and Solutions
7.3.4 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Endo Pharma Recent Developments
7.4 Endo Pharma
7.4.1 Endo Pharma Profile
7.4.2 Endo Pharma Main Business
7.4.3 Endo Pharma Post herpetic Neuralgia Treatment Products, Services and Solutions
7.4.4 Endo Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Endo Pharma Recent Developments
7.5 Teikoku Pharma
7.5.1 Teikoku Pharma Profile
7.5.2 Teikoku Pharma Main Business
7.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Products, Services and Solutions
7.5.4 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Teikoku Pharma Recent Developments
7.6 Teva
7.6.1 Teva Profile
7.6.2 Teva Main Business
7.6.3 Teva Post herpetic Neuralgia Treatment Products, Services and Solutions
7.6.4 Teva Post herpetic Neuralgia Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Teva Recent Developments
7.7 Mylan
7.7.1 Mylan Profile
7.7.2 Mylan Main Business
7.7.3 Mylan Post herpetic Neuralgia Treatment Products, Services and Solutions
7.7.4 Mylan Post herpetic Neuralgia Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Mylan Recent Developments
7.8 Hengrui Medicine
7.8.1 Hengrui Medicine Profile
7.8.2 Hengrui Medicine Main Business
7.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Products, Services and Solutions
7.8.4 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Hengrui Medicine Recent Developments
8 Industry Chain Analysis
8.1 Post herpetic Neuralgia Treatment Industrial Chain
8.2 Post herpetic Neuralgia Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Post herpetic Neuralgia Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Post herpetic Neuralgia Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Post herpetic Neuralgia Treatment Market Trends
    Table 2. Post herpetic Neuralgia Treatment Market Drivers & Opportunity
    Table 3. Post herpetic Neuralgia Treatment Market Challenges
    Table 4. Post herpetic Neuralgia Treatment Market Restraints
    Table 5. Global Post herpetic Neuralgia Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Post herpetic Neuralgia Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Post herpetic Neuralgia Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Post herpetic Neuralgia Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Post herpetic Neuralgia Treatment
    Table 10. Global Post herpetic Neuralgia Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post herpetic Neuralgia Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Post herpetic Neuralgia Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Post herpetic Neuralgia Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Post herpetic Neuralgia Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Post herpetic Neuralgia Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Post herpetic Neuralgia Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Post herpetic Neuralgia Treatment Sales Value by Distribution Channel: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Post herpetic Neuralgia Treatment Sales Value by Distribution Channel (2019-2024) & (US$ Million)
    Table 20. Global Post herpetic Neuralgia Treatment Sales Value by Distribution Channel (2025-2030) & (US$ Million)
    Table 21. Global Post herpetic Neuralgia Treatment Sales Market Share in Value by Distribution Channel (2019-2024) & (%)
    Table 22. Global Post herpetic Neuralgia Treatment Sales Market Share in Value by Distribution Channel (2025-2030) & (%)
    Table 23. Global Post herpetic Neuralgia Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Post herpetic Neuralgia Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Post herpetic Neuralgia Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Post herpetic Neuralgia Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Post herpetic Neuralgia Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Post herpetic Neuralgia Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Post herpetic Neuralgia Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Post herpetic Neuralgia Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Pfizer Basic Information List
    Table 32. Pfizer Description and Business Overview
    Table 33. Pfizer Post herpetic Neuralgia Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Post herpetic Neuralgia Treatment Business of Pfizer (2019-2024)
    Table 35. Pfizer Recent Developments
    Table 36. Arbor Pharma Basic Information List
    Table 37. Arbor Pharma Description and Business Overview
    Table 38. Arbor Pharma Post herpetic Neuralgia Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Post herpetic Neuralgia Treatment Business of Arbor Pharma (2019-2024)
    Table 40. Arbor Pharma Recent Developments
    Table 41. Assertio Therapeutics Basic Information List
    Table 42. Assertio Therapeutics Description and Business Overview
    Table 43. Assertio Therapeutics Post herpetic Neuralgia Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Post herpetic Neuralgia Treatment Business of Assertio Therapeutics (2019-2024)
    Table 45. Assertio Therapeutics Recent Developments
    Table 46. Endo Pharma Basic Information List
    Table 47. Endo Pharma Description and Business Overview
    Table 48. Endo Pharma Post herpetic Neuralgia Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Post herpetic Neuralgia Treatment Business of Endo Pharma (2019-2024)
    Table 50. Endo Pharma Recent Developments
    Table 51. Teikoku Pharma Basic Information List
    Table 52. Teikoku Pharma Description and Business Overview
    Table 53. Teikoku Pharma Post herpetic Neuralgia Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Post herpetic Neuralgia Treatment Business of Teikoku Pharma (2019-2024)
    Table 55. Teikoku Pharma Recent Developments
    Table 56. Teva Basic Information List
    Table 57. Teva Description and Business Overview
    Table 58. Teva Post herpetic Neuralgia Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Post herpetic Neuralgia Treatment Business of Teva (2019-2024)
    Table 60. Teva Recent Developments
    Table 61. Mylan Basic Information List
    Table 62. Mylan Description and Business Overview
    Table 63. Mylan Post herpetic Neuralgia Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Post herpetic Neuralgia Treatment Business of Mylan (2019-2024)
    Table 65. Mylan Recent Developments
    Table 66. Hengrui Medicine Basic Information List
    Table 67. Hengrui Medicine Description and Business Overview
    Table 68. Hengrui Medicine Post herpetic Neuralgia Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Post herpetic Neuralgia Treatment Business of Hengrui Medicine (2019-2024)
    Table 70. Hengrui Medicine Recent Developments
    Table 71. Key Raw Materials Lists
    Table 72. Raw Materials Key Suppliers Lists
    Table 73. Post herpetic Neuralgia Treatment Downstream Customers
    Table 74. Post herpetic Neuralgia Treatment Distributors List
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
    Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Post herpetic Neuralgia Treatment Product Picture
    Figure 2. Global Post herpetic Neuralgia Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Post herpetic Neuralgia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Post herpetic Neuralgia Treatment Report Years Considered
    Figure 5. Global Post herpetic Neuralgia Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Post herpetic Neuralgia Treatment Revenue in 2023
    Figure 7. Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Anticonvulsants Picture
    Figure 9. Skin Patch Picture
    Figure 10. Other Picture
    Figure 11. Global Post herpetic Neuralgia Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Post herpetic Neuralgia Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospital Pharmacies
    Figure 14. Product Picture of Online Pharmacies
    Figure 15. Product Picture of Retail Pharmacies
    Figure 16. Global Post herpetic Neuralgia Treatment Sales Value by Distribution Channel (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Post herpetic Neuralgia Treatment Sales Value Market Share by Distribution Channel, 2023 & 2030
    Figure 18. North America Post herpetic Neuralgia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Post herpetic Neuralgia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Post herpetic Neuralgia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Post herpetic Neuralgia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Post herpetic Neuralgia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Post herpetic Neuralgia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Post herpetic Neuralgia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Post herpetic Neuralgia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Post herpetic Neuralgia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Post herpetic Neuralgia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Post herpetic Neuralgia Treatment Sales Value (%), (2019-2030)
    Figure 29. United States Post herpetic Neuralgia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Post herpetic Neuralgia Treatment Sales Value by Distribution Channel (%), 2023 VS 2030
    Figure 32. Europe Post herpetic Neuralgia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Post herpetic Neuralgia Treatment Sales Value by Distribution Channel (%), 2023 VS 2030
    Figure 35. China Post herpetic Neuralgia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Post herpetic Neuralgia Treatment Sales Value by Distribution Channel (%), 2023 VS 2030
    Figure 38. Japan Post herpetic Neuralgia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Post herpetic Neuralgia Treatment Sales Value by Distribution Channel (%), 2023 VS 2030
    Figure 41. South Korea Post herpetic Neuralgia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Post herpetic Neuralgia Treatment Sales Value by Distribution Channel (%), 2023 VS 2030
    Figure 44. Southeast Asia Post herpetic Neuralgia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Post herpetic Neuralgia Treatment Sales Value by Distribution Channel (%), 2023 VS 2030
    Figure 47. India Post herpetic Neuralgia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Post herpetic Neuralgia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Post herpetic Neuralgia Treatment Sales Value by Distribution Channel (%), 2023 VS 2030
    Figure 50. Post herpetic Neuralgia Treatment Industrial Chain
    Figure 51. Post herpetic Neuralgia Treatment Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS